The winners, Nathan Gates, Faith Apostolodes, and Kevin Helm have shared some insights as to what inspired their winning ...

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

DIA, a global multidisciplinary life sciences membership association, will bring together thousands of stakeholders from all ...

The first shot taken at Medicaid, likely UnitedHealthcare coverage for Vertex's pain drug, and Optum’s wellness visit ad.

If you are a Gemini Advanced subscriber, you can access Gemini 2.0 Pro through the model-picker menu on both desktop and ...

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

One sickle cell patient told ITV News the new gene therapy being rolled out for use on the NHS means they "finally have something to look towards". | ITV National News ...

Tah modified the traditional vertex model by allowing the preferred perimeter of the cells—the target size and shape that cells naturally try to maintain—to shrink linearly over time.

Vertex' outgoing R&D chief Peter Mueller - who has just announced his retirement - must feel he is leaving the company in fine shape.

He also hinted at major announcements scheduled for February 4, when Krutrim will disclose details about its AI lab, state-of ...